These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20698501)

  • 1. Structural mass spectrometry in protein therapeutics discovery.
    Kim YJ; Doyle ML
    Anal Chem; 2010 Sep; 82(17):7083-9. PubMed ID: 20698501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.
    Katsila T; Siskos AP; Tamvakopoulos C
    Mass Spectrom Rev; 2012; 31(1):110-33. PubMed ID: 21698655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-based technologies for target discovery.
    Valle RP; Jendoubi M
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):197-203. PubMed ID: 12669455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry in the standardisation of recombinant products.
    Geisow MJ
    Dev Biol Stand; 1994; 83():129-33. PubMed ID: 7883085
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.
    Chen G; Warrack BM; Goodenough AK; Wei H; Wang-Iverson DB; Tymiak AA
    Drug Discov Today; 2011 Jan; 16(1-2):58-64. PubMed ID: 21093608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals.
    Srebalus Barnes CA; Lim A
    Mass Spectrom Rev; 2007; 26(3):370-88. PubMed ID: 17410555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis.
    Thompson NJ; Rosati S; Rose RJ; Heck AJ
    Chem Commun (Camb); 2013 Jan; 49(6):538-48. PubMed ID: 23183499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
    Wabnitz PA; Loo JA
    Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput characterization and quality control of small-molecule combinatorial libraries.
    Kenseth JR; Coldiron SJ
    Curr Opin Chem Biol; 2004 Aug; 8(4):418-23. PubMed ID: 15288253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry for structural characterization of therapeutic antibodies.
    Zhang Z; Pan H; Chen X
    Mass Spectrom Rev; 2009; 28(1):147-76. PubMed ID: 18720354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals.
    Salehpour M; Ekblom J; Sabetsky V; Håkansson K; Possnert G
    Rapid Commun Mass Spectrom; 2010 May; 24(10):1481-9. PubMed ID: 20411588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of molecular targets of natural products by mass spectrometry.
    Cheng KW; Wong CC; Wang M; He QY; Chen F
    Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide and protein drug analysis by MS: challenges and opportunities for the discovery environment.
    Campbell JL; Le Blanc JC
    Bioanalysis; 2011 Mar; 3(6):645-57. PubMed ID: 21417733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Going global: protein expression profiling using shotgun mass spectrometry.
    Kislinger T; Emili A
    Curr Opin Mol Ther; 2003 Jun; 5(3):285-93. PubMed ID: 12870439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
    Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
    Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical applications of mass spectrometry in pharmaceutical drug discovery.
    Geoghegan KF; Kelly MA
    Mass Spectrom Rev; 2005; 24(3):347-66. PubMed ID: 15389851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics.
    Posner BA
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):487-94. PubMed ID: 16022185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.
    Annis DA; Nickbarg E; Yang X; Ziebell MR; Whitehurst CE
    Curr Opin Chem Biol; 2007 Oct; 11(5):518-26. PubMed ID: 17931956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC/MS applications in drug development.
    Lee MS; Kerns EH
    Mass Spectrom Rev; 1999; 18(3-4):187-279. PubMed ID: 10568041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.